~~<i id='59BB778B83'><strike id='59BB778B83'><tt id='59BB778B83'><pre id='59BB778B83'></pre></tt></strike></i>~~

Home» leisure time» entertainment

entertainment

author：leisure time 2025-09-27 17:09:45 Page View：6497

CMS Administrator Chiquita Brooks-LaSure Chip Somodevilla/Getty Images

WASHINGTON — Eli Lilly’s latest anti-amyloid Alzheimer’s treatment seems to slow the disease, the company announced this week — news that adds even more pressure on Medicare’s unprecedented restrictions on coverage.

Medicare has so far held firm on its plans to require patient registries for the entire class of anti-amyloid Alzheimer’s drugs, even after they are fully approved.

Pharmaceutical groups and patient advocates are increasingly fighting that approach.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： O'Shea Sibley was killed after expressing queer joy by voguing, activists say
Next article： Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

explore

Dobbs anniversary: the lost opportunity of abortion as health care

NathanHoward/GettyImagesReflectingonthisfirstanniversaryoftheSupremeCourt’sdecisioninDobbstooverturn

Newly revealed memo details efforts to keep Trump in power following election loss

2:14PresidentDonaldTrumpspeakstosupportersfromTheEllipseneartheWhiteHouseonJanuary6,2021,inWashingto

Activists slam private health insurers over coverage restrictions

ProtestorsoutsideAmerica'sHealthInsurancePlansheadquarters.CourtesyPeople'sActionWASHINGTON—Hun

Some of the ways extreme heat will change life as we know it

1:18AtourguidefansherselfwhileworkinginTimesSquareastemperaturesrise,July27,2023,inNewYorkCity.JohnM